Barrett??s Oesophagus
- 1 January 2003
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 63 (6) , 555-564
Abstract
Evidence to support the association between Barrett’s oesophagus and GORD appears to be strong but circumstantial. The intermediate steps that lead from GORD to Barrett’s oesophagus are speculative and the timeline for the development of this condition remains obscure. It has yet to be demonstrated that erosive oesophagitis is a necessary intermediate step for the development of Barrett’s oesophagus. In spite of effective therapy, documentation that medical or surgical therapyprevents Barrett’s oesophagus is lacking. The goal of screening for Barrett’s oesophagus is ultimately to improve the survival of patients with adenocarcinoma of the oesophagus. This goal has not been achieved and the evidence-based criteria for screening remain to be defined. Medical and surgical therapy of Barrett’s oesophagus iseffective in controlling reflux, although not proven to prevent neoplastic progression of the at risk mucosa. Endoscopic techniques of mucosal injury have been applied as alternatives to oesophagectomy in efforts to prevent progression to cancer. Surveillance endoscopy and biopsy is the currently accepted method aimed at early intervention and improved survival for oesophageal adenocarcinoma. A working surveillance protocol to accomplish this is proposed based on dysplasia grade. If no dysplasia is found and confirmed with subsequent endoscopy and biopsy, a 3-year interval is recommended. If only low grade dysplasia is confirmed, then annual endoscopy until no dysplasia is recognised is recommended. On the basis of defined risk factors, high grade dysplasia can lead to intense surveillance every 3 months or an intervention. Future developments in understanding the biology of Barrett’s oesophagus and in therapeutic interventions will provide an opportunity for more effective screening, surveillance and prevention of neoplastic progression.Keywords
This publication has 100 references indexed in Scilit:
- Failure of oesophageal acid control in candidates for Barrett's oesophagus reversal on a very high dose of proton pump inhibitorAlimentary Pharmacology & Therapeutics, 2000
- Long-term results of classic antireflux surgery in 152 patients with Barrett's esophagus: Clinical, radiologic, endoscopic, manometric, and acid reflux test analysis before and late after operationSurgery, 1998
- The gastroesophageal flap valve: in vitro and in vivo observationsGastrointestinal Endoscopy, 1996
- Reversal of Barrett's esophagus with acid suppression and multipolar electrocoagulation: preliminary resultsGastrointestinal Endoscopy, 1996
- Gastric acid and pepsin secretion in patients with Barrett's esophagus and appropriate controlsDigestive Diseases and Sciences, 1996
- Clinical characteristics and natural history of symptomatic but not excess gastroesophageal refluxDigestive Diseases and Sciences, 1995
- Unsedated trans-nasal pharyngoesophagogastroduodenoscopy (T-EGD): TechniqueGastrointestinal Endoscopy, 1994
- Outcome 5 years after 3600° fundoplication for gastro-oesophageal reflux diseaseBritish Journal of Surgery, 1993
- Correlation between basal acid output and daily ranitidine dose required for therapy in Barrett's esophagusDigestive Diseases and Sciences, 1992
- Barrett's EsophagusNew England Journal of Medicine, 1986